SCHEMBL4554124

SCHEMBL4554124

OC(O)CCSS.[NaH].[NaH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10908427 0.97
SCHEMBL4239769 0.79
SCHEMBL2846020 0.77
SCHEMBL16500034 0.69 TSHR (0.30)
SCHEMBL11237346 0.69 BHMT (0.36)
SCHEMBL4555726 0.67
SCHEMBL15409111 0.65
SCHEMBL5533408 0.65
SCHEMBL22334183 0.65
SCHEMBL11281057 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120905-A1 METHODS, COMPOUNDS, AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS AND DIABETES BELLUS Health (International) Limited (CH) 2009-11-25 EP disclosed
EP-1968561-A2 TREATMENT OF RENAL DISORDERS, DIABETIC NEPHROPATHY AND DYSLIPIDEMIAS Neurochem (International) Limited (CH) 2008-09-17 EP disclosed
WO-2008078176-A1 METHODS, COMPOUNDS, AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS AND DIABETES BELLUS HEALTH (INTERNATIONAL) LIMITED (US) 2008-07-03 WO disclosed
EP-1885350-A2 FORMULATIONS AND METHODS FOR TREATING AMYLOIDOSIS Neurochem (International) Limited (CH) 2008-02-13 EP disclosed
WO-2007125385-A2 TREATMENT OF RENAL DISORDERS, DIABETIC NEPHOPATHY AND DYSLIPIDEMIAS NEUROCHEM (INTERNATIONAL) LIMITED (US) 2007-11-08 WO disclosed
WO-2007004072-A2 FORMULATIONS AND METHODS FOR TREATING AMYLOIDOSIS NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2007-01-11 WO disclosed